Advertisement

 

 

Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour : Results from a four-year longitudinal study.

Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour : Results from a four-year longitudinal study.
Author Information (click to view)

Brouwers C, Hooftman B, Vonk S, Vonk A, Stooker W, Te Gussinklo WH, Wesselink RM, Wagner C, de Bruijne MC,


Brouwers C, Hooftman B, Vonk S, Vonk A, Stooker W, Te Gussinklo WH, Wesselink RM, Wagner C, de Bruijne MC, (click to view)

Brouwers C, Hooftman B, Vonk S, Vonk A, Stooker W, Te Gussinklo WH, Wesselink RM, Wagner C, de Bruijne MC,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 25(3) 207-214 doi 10.1007/s12471-016-0936-1
Abstract
INTRODUCTION
Cardiac operations account for a large proportion of the blood transfusions given each year, leading to high costs and an increased risk to patient safety. Therefore, it is important to explore initiatives to reduce transfusion rates. This study aims to provide a benchmark for transfusion practice by inter-hospital comparison of transfusion rates, blood product use and costs related to patients undergoing coronary artery bypass grafting (CABG), valve surgery or combined CABG and valve surgery.

METHODS
Between 2010 and 2013, patients from four Dutch hospitals undergoing CABG, valve surgery or combined CABG and valve surgery (n = 11,150) were included by means of a retrospective longitudinal study design.

RESULTS
In CABG surgery the transfusion rate ranged between 43 and 54%, in valve surgery between 54 and 67%, and in combined CABG and valve surgery between 80 and 88%. With the exception of one hospital, the trend in transfusion rate showed a significant decrease over time for all procedures. Hospitals differed significantly in the units of blood products given to each patient, and in the use of specific transfused combinations of blood products, such as red blood cells (RBCs) and a combination of RBCs, fresh frozen plasma (FFP) and platelets.

CONCLUSION
This study indicates that benchmarking blood product usage stimulates awareness of transfusion behaviour, which may lead to better patient safety and lower costs. Further studies are warranted to improve awareness of transfusion behaviour and increase the standardisation of transfusion practice in cardiac surgery.

Submit a Comment

Your email address will not be published. Required fields are marked *

2 + 12 =

[ HIDE/SHOW ]